Envoy Medical Inc.
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; audi… Read more
Envoy Medical Inc. (COCH) - Total Assets
Latest total assets as of September 2025: $8.18 Million USD
Based on the latest financial reports, Envoy Medical Inc. (COCH) holds total assets worth $8.18 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Envoy Medical Inc. - Total Assets Trend (2020–2024)
This chart illustrates how Envoy Medical Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Envoy Medical Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Envoy Medical Inc.'s total assets of $8.18 Million consist of 81.3% current assets and 18.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 47.5% |
| Accounts Receivable | $818.00K | 7.1% |
| Inventory | $1.71 Million | 14.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Envoy Medical Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Envoy Medical Inc.'s current assets represent 81.3% of total assets in 2024, an increase from 20.8% in 2020.
- Cash Position: Cash and equivalents constituted 47.5% of total assets in 2024, up from 20.8% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 14.8% of total assets.
Envoy Medical Inc. Competitors by Total Assets
Key competitors of Envoy Medical Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Envoy Medical Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Envoy Medical Inc. generates 0.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Envoy Medical Inc. is currently not profitable relative to its asset base.
Envoy Medical Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.64 | 0.79 | 3.09 |
| Quick Ratio | 0.46 | 0.61 | 3.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.23 Million | $ -1.94 Million | $ 3.50 Million |
Envoy Medical Inc. - Advanced Valuation Insights
This section examines the relationship between Envoy Medical Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.22 |
| Latest Market Cap to Assets Ratio | 1.30 |
| Asset Growth Rate (YoY) | 39.5% |
| Total Assets | $11.54 Million |
| Market Capitalization | $15.04 Million USD |
Valuation Analysis
Above Book Valuation: The market values Envoy Medical Inc.'s assets above their book value (1.30 x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Envoy Medical Inc.'s assets grew by 39.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Envoy Medical Inc. (2020–2024)
The table below shows the annual total assets of Envoy Medical Inc. from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $11.54 Million | +39.50% |
| 2023-12-31 | $8.27 Million | +223.59% |
| 2022-12-31 | $2.56 Million | -2.59% |
| 2021-12-31 | $2.62 Million | +2086.81% |
| 2020-12-31 | $119.99K | -- |